Brief: Aurinia Pharmaceuticals Q1 EPS USD -0.07
02/05/2024 11:00
May 02 (Reuters) - Aurinia Pharmaceuticals Q1 product revenue USD 48.073 million. * Q1 net income USD -10.749 million * Q1 operating income USD -13.253 million * Q1 pretax profit USD -10.01 million
Recent news on Aurinia Pharmaceuticals
See all newsBrief: Aurinia Settles Patent Litigation With Teva
Canada's Aurinia Q2 revenue rises on LUPKYNIS sales
Brief: Aurinia Pharmaceuticals Q2 Pretax Profit USD 48.786 Million
Aurinia Pharmaceuticals Inc expected to post earnings of 24 cents a share - Earnings Preview
Brief: Lupkynis Associated With A Statistically Significant 53% Reduction In Risk Of Renal-Related Event Or Death